Correlates and disparities of intention to vaccinate against COVID-19

Timothy Callaghan, Ali Moghtaderi, Jennifer A. Lueck, +5

Social Science & Medicine

VaccinationPreventive MedicineVaccine SurveillanceCovid-19 PandemicVaccine Efficacy +5

Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention

Sarah M. Bartsch, Kelly J. O’Shea, Marie C. Ferguson, +8

American Journal of Preventive Medicine

VaccinationVaccine SafetyCovid-19 PandemicVaccine Efficacy NeededVaccine Efficacy +6

Correlates and Disparities of COVID-19 Vaccine Hesitancy

Timothy Callaghan, Ali Moghtaderi, Jennifer A. Lueck, +5

SSRN Electronic Journal

Identification of vaccine targets in pathogens and design of a vaccine using computational approaches

Kamal Rawal, Robin Sinha, Bilal Ahmed Abbasi, +18

Scientific Reports

ImmunologyReverse VaccinologyVaccine TargetProteomicsAntigen Identification +17

Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate

Wen‐Hsiang Chen, Shivali Chag, Mohan‐Vivekanandan Poongavanam, +10

Journal of Pharmaceutical Sciences

VaccinationVaccine DevelopmentVaccine TargetImmunologyProduction Process +5

A method to probe protein structure from UV absorbance spectra

Amadeo B. Biter, Jeroen Pollet, Wen‐Hsiang Chen, +3

Analytical Biochemistry

Protein ChemistryBiochemistryUv-vis SpectroscopyProtein FoldingMedicine +1

Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement

Wen‐Hsiang Chen, Xinrong Tao, Anurodh Shankar Agrawal, +10

Vaccine

Host ResponseImmunologyAntiviral ResponseImmunotherapyMedicine +2

An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice

Etsuro Nanishi, Francesco Borriello, Timothy R. O’Meara, +43

Science Translational Medicine

VaccinationGlobal DeploymentVaccine DevelopmentVaccine TargetAluminum Hydroxide +10

SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice

Jeroen Pollet, Wen‐Hsiang Chen, Leroy Versteeg, +17

Human Vaccines & Immunotherapeutics

The 1.9 Å Crystal Structure of Alanine Racemase from <i>Mycobacterium tuberculosis</i> Contains a Conserved Entryway into the Active Site^,

Pierre LeMagueres, Hookang Im, Jerry O. Ebalunode, +5

Biochemistry